Header Logo

Connection

GHAZALEH ESKANDARI to Receptor, IGF Type 1

Back to Details
This is a "connection" page, showing publications GHAZALEH ESKANDARI has written about Receptor, IGF Type 1.
GHAZALEH ESKANDARI
Connection Strength
0.158
Receptor, IGF Type 1
  1. Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma. J Hematol Oncol. 2019 07 24; 12(1):80.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.